BSX Q4 2023 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.7B+14.9% YoY

Gross Profit

$2.3B62.1% margin

Operating Income

$558M15.0% margin

Net Income

$504M13.5% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

+5.6%

Cash Flow

Operating Cash Flow

$957M

Free Cash Flow

$690M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$35.1B

Total Liabilities

$15.6B

Stockholders' Equity

$19.3B

Cash & Equivalents

$865M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.7B	$3.2B	+14.9%
Gross Profit	$2.3B	$2.0B	+18.3%
Operating Income	$558M	$449M	+24.3%
Net Income	$504M	$140M	+260.0%

Revenue Segments

Cardiovascular

$2.3B61%

MedSurg

$1.4B39%

Geographic Segments

UNITED STATES

$2.2B59%

Non-US

$1.5B41%